Title : Rivastigmine in frontotemporal dementia: an open-label study.

Pub. Date : 2004

PMID : 15554751






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: This preliminary open-label study aims to investigate the effects of rivastigmine, an inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), in 20 patients diagnosed with frontotemporal dementia (FTD). Rivastigmine acetylcholinesterase (Cartwright blood group) Homo sapiens
2 OBJECTIVE: This preliminary open-label study aims to investigate the effects of rivastigmine, an inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), in 20 patients diagnosed with frontotemporal dementia (FTD). Rivastigmine acetylcholinesterase (Cartwright blood group) Homo sapiens